What is Roth Capital’s Forecast for Curaleaf Q3 Earnings?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Equities research analysts at Roth Capital lowered their Q3 2025 earnings per share (EPS) estimates for Curaleaf in a report released on Tuesday, March 4th. Roth Capital analyst W. Kirk now expects that the company will post earnings per share of ($0.06) for the quarter, down from their previous forecast of ($0.05). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Roth Capital also issued estimates for Curaleaf’s Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.23) EPS and FY2026 earnings at ($0.19) EPS.

Separately, Cormark cut Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.

Curaleaf Price Performance

Shares of CURLF opened at $1.11 on Thursday. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. Curaleaf has a 1 year low of $0.88 and a 1 year high of $6.40. The stock has a market cap of $733.29 million, a P/E ratio of -3.83 and a beta of 0.57. The stock’s 50-day moving average price is $1.44 and its two-hundred day moving average price is $2.18.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings results on Monday, March 3rd. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.09. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%. The business had revenue of $331.05 million for the quarter, compared to analysts’ expectations of $331.87 million.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.